+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

Japan Psoriasis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Psoriasis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Japan Rheumatoid Arthritis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Rheumatoid Arthritis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Ulcerative Colitis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Ulcerative Colitis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 190 Pages
  • Global
From
Axial Spondyloarthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 - Product Thumbnail Image

Axial Spondyloarthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

  • Report
  • June 2023
  • 112 Pages
  • Global
From
TNF Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

TNF Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 115 Pages
  • Global
From
Psoriasis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts ((2022 - 2027) - Product Thumbnail Image

Psoriasis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts ((2022 - 2027)

  • Report
  • June 2022
  • 120 Pages
  • Global
From
Adalimumab Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Adalimumab Drugs Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 140 Pages
  • Global
From
Interleukin Inhibitors Market Report and Forecast 2024-2032 - Product Thumbnail Image

Interleukin Inhibitors Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
Cancer Cachexia Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Cachexia Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Tumor Necrosis Factor Receptor Superfamily Member 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 70 Pages
  • Global
From
Crohn's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Crohn's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 139 Pages
  • Global
From
Autoimmune Hepatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Autoimmune Hepatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • October 2021
  • 288 Pages
  • Global
From
Autoimmune Drugs Market 2024-2028 - Product Thumbnail Image

Autoimmune Drugs Market 2024-2028

  • Report
  • July 2024
  • 185 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market 2024-2028 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 174 Pages
  • Global
From
Psoriasis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Psoriasis Treatment Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
Anti-rheumatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Drug Class Coverage, Type Coverage, Geographic Coverage and By Company) - Product Thumbnail Image

Anti-rheumatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Drug Class Coverage, Type Coverage, Geographic Coverage and By Company)

  • Report
  • June 2024
  • 200 Pages
  • Global
From
TNF Alpha Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

TNF Alpha Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • November 2024
  • 150 Pages
  • Global
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more